Terbutaline Sulfate
NDC 0527-1318, Terbutaline Sulfate, tablet, from Lannett Company, Inc..
- Product NDC
- 0527-1318
- Status
- Listed
- Labeler
- Lannett Company, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA077152
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0527-1318 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERBUTALINE SULFATE2.5 mg/1
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0527-1318-01 | 00527131801 | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| 0527-1318-10 | 00527131810 | 1000 TABLET in 1 BOTTLE (0527-1318-10) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/fbf54709-5857-4dbc-9233-ebd7abff88c8NADAC price for package 00527131801
GET /v1/drugs/nadac/00527131801
Use it
Look up 0527-1318 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0527-1318 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0527-1318. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.